CCL2 actives the COX-2/PGE2 pathway to accelerate the tumorgenesis of colorectal cancer via FoxO1 de

来源 :2019中国肿瘤学大会 | 被引量 : 0次 | 上传用户：yjqwml

【摘要】

：

Objective CCL2(Chemokine ligand-2)is a multifunctional factor,by acting via its receptor CCR2(chemokine receptor 2)which is expressed on monocytes and macrophages.

【作者】

：

Dongsheng Yu Jiye Li Sanyang Chen Wenzhi Guo Shuijun Zhang

【机构】

：

The First Affiliated Hospital of Zhengzhou University

【出处】

：

2019中国肿瘤学大会

【发表日期】

：

2019年7期

【关键词】

：

CCL2 colorectal cancer cyclooxygenase-2 prostaglandin E2 FoxO1

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective CCL2(Chemokine ligand-2)is a multifunctional factor,by acting via its receptor CCR2(chemokine receptor 2)which is expressed on monocytes and macrophages.

其他文献

Polypyrrole Based Multistimuli-Responsive Nanoparticles for Targeted Chemo-Photothermal Synergistic

Objective Over the years,the incidence of recurrence and aggressive type of thyroid cancer has continuously increased.[1] There still be some problems with traditional strategies for the treatment of

会议

Thyroid cancerChemo-photothermal therapyDrug deliveryNanomedicinePolypyrrole

An effective strategy to eliminate inherent crosscontamination in mtDNA next-generation sequencing o

Objective The mitochondrion,an organelle playing crucial roles in many basic cellular processes,contains its own genome,mitochondrial DNA(mtDNA).

会议

LncRNA profiles between IDH wildtype and mutant Glioblastomas identified a stem-related lncRNA bioma

Objective Glioblastomas(GBMs)are divided into IDH mutant(IDHMT)and wildtype(IDHWT)subtypes,each subtype presents totally different tumor behaviors and patients prognosis.

会议

mtDNA单核苷酸多态性和单倍型与结直肠癌发病风险及预后的相关性研究

目的我国癌症发生率处于快速上升期,结直肠癌(CRC)在所有肿瘤中发病率居于第三位,死亡率居于第五位.CRC 的早期发现及其预后评估具有重要临床意义.目前,血清生物标志物是CRC 早期筛查和预后预测的常用方法,然而,CEA 或CA19-9 等标志物的检测灵敏度较低.

会议

结直肠癌线粒体DNA单核苷酸多态性单倍型

Norcantharidin suppressed cell migration and invasion by modulating the β-catenin/miR-301a/ZBTB4 sig

Objective PURPOSE: Breast cancer is the leading malignant tumor in women worldwide.Since not responding to endocrine therapy and anti-human epidermal growth factor receptor 2(HER2)therapy,triple-negat

会议

Photoactive nanoparticles for Cooperative Cancer Therapy

Objective High-performance photosensitizers are highly desired for achieving selective tumor photoablation in the field of precise cancer therapy.

会议

nanoparticlesphototherapyBodipycooperative therapyconjugated photosensitizer

线粒体融合蛋白1缺失促进肝癌发生发展

目的肝细胞肝癌(Hepatocellular carcinoma,HCC)是我国最常见的恶性肿瘤疾病之一,恶性肿瘤死亡率高居我国第二位,因此更多的预防及治疗肝癌的新靶点亟待发现。线粒体是调控细胞代谢最重要的细胞器,通过不断地分裂/融合调控自身功能并对外界刺激做出适应性反应。

会议

线粒体融合蛋白1肝癌

PD-L1 expression in uncommon EGFR-mutant non-small cell lung cancer and its response to immunotherap

Objective The efficacy of immunotherapy treating EGFR-positive non-small cell lung cancer(NSCLC)patients has been proved to be limited.However,a series of mutantpatients could benefit from PD-1 blocka

会议

PD-L1EGFRUncommonimmunotherapy

Fasting induces HCC apoptosis via inhibition of SET8 expression

Objective Hepatocellular carcinoma(HCC)is a life-threatening cancer and exhibits resistance to apoptosis.Fasting is reported to be associated with a decrease in tumor growth and induction of apoptosis

会议

SET8PGC1αfastingKeap1Hepatocellular carcinoma

YIPF2 is a novel Rab-GDF that enhances the HCC malignant phenotypes by facilitating CD147 endocytic

Objective Increased surface level of CIE(clathrin-independent endocytosis)proteins is a new feature of malignant neoplasms.CD147(EMMPRIN or Basigin)antigen is a multifunctional CIE glycoprotein highly

会议

CCL2 actives the COX-2/PGE2 pathway to accelerate the tumorgenesis of colorectal cancer via FoxO1 de

与本文相关的学术论文